Rob S van Binnendijk - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Rob S van Binnendijk

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

JAMA Oncology|August 11, 2022

Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19Sabine Haggenburg, Quincy Hofsink, Birgit I Lissenberg-Witte, et al.

Blood Advances|February 3, 2022

Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patientsSabine Haggenburg, Birgit I Lissenberg-Witte, Rob S van Binnendijk, et al.

Blood Advances|February 24, 2026

Humoral and cellular immune response after COVID-19 vaccination in patients with sickle cell disease on hydroxyureaSabine Haggenburg, Cilia R Pothast, Quincy Hofsink, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

JAMA Oncology|August 11, 2022

Blood Advances|February 3, 2022

Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patientsSabine Haggenburg, Birgit I Lissenberg-Witte, Rob S van Binnendijk, et al.

Blood Advances|February 24, 2026

Humoral and cellular immune response after COVID-19 vaccination in patients with sickle cell disease on hydroxyureaSabine Haggenburg, Cilia R Pothast, Quincy Hofsink, et al.

Pageof 4